Dataset Information


Cardioprotection by the mitochondrial unfolded protein response requires ATF5.

ABSTRACT: The mitochondrial unfolded protein response (UPRmt) is a cytoprotective signaling pathway triggered by mitochondrial dysfunction. UPRmt activation upregulates chaperones, proteases, antioxidants, and glycolysis at the gene level to restore proteostasis and cell energetics. Activating transcription factor 5 (ATF5) is a proposed mediator of the mammalian UPRmt. Herein, we hypothesized pharmacological UPRmt activation may protect against cardiac ischemia-reperfusion (I/R) injury in an ATF5-dependent manner. Accordingly, in vivo administration of the UPRmt inducers oligomycin or doxycycline 6 h before ex vivo I/R injury (perfused heart) was cardioprotective in wild-type but not global Atf5-/- mice. Acute ex vivo UPRmt activation was not cardioprotective, and loss of ATF5 did not impact baseline I/R injury without UPRmt induction. In vivo UPRmt induction significantly upregulated many known UPRmt-linked genes (cardiac quantitative PCR and Western blot analysis), and RNA-Seq revealed an UPRmt-induced ATF5-dependent gene set, which may contribute to cardioprotection. This is the first in vivo proof of a role for ATF5 in the mammalian UPRmt and the first demonstration that UPRmt is a cardioprotective drug target.NEW & NOTEWORTHY Cardioprotection can be induced by drugs that activate the mitochondrial unfolded protein response (UPRmt). UPRmt protection is dependent on activating transcription factor 5 (ATF5). This is the first in vivo evidence for a role of ATF5 in the mammalian UPRmt.

PROVIDER: S-EPMC6732477 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC7262932 | BioStudies
| S-EPMC4980197 | BioStudies
| S-EPMC7725676 | BioStudies
| S-EPMC8280182 | BioStudies
| S-EPMC7493924 | BioStudies
| S-EPMC8632273 | BioStudies
| S-EPMC6456800 | BioStudies
2017-01-01 | S-EPMC5307469 | BioStudies
| E-GEOD-75410 | BioStudies
| E-GEOD-75247 | BioStudies